Columnist Desiree Lama describes her journey with MS-related bladder problems that were brought under control but are now ...

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

Receiving a multiple sclerosis (MS) diagnosis can feel like being flung into an upside-down life. There’s new lingo to be learned, the dread of treatments, and the strangeness of the body ...

Managing multiple sclerosis (MS) can be challenging, but you don’t have to do it alone. “Get Tough on Multiple Sclerosis” is an all-new, physician-led video series designed to encourage and ...

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

What is Ocrevus for MS? Ocrevus (ocrelizumab) is an approved infusion therapy that’s indicated for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome ...